About the offering
Formae is a medical device company that is developing CyborGel®, a synthetic hydrogel cartilage implant to treat early-stage knee osteoarthritis, in Villanova, Pennsylvania.
FAQ
How much has Formae, Inc. raised?
Formae, Inc. has raised $358,154 of a $5M goal.
Where is Formae, Inc.'s campaign live?
The offering is live on StartEngine, an SEC-registered Reg CF intermediary.
What are the terms of Formae, Inc.'s raise?
Common Stock, $49.38M cap, $2.75/share.
When does Formae, Inc.'s offering close?
The stated close date is Jan 11, 2027.